Marc A. Cohen, Director, 10% Owner at C4 Therapeutics, Inc. (CCCC), bought 242,179 shares at $19.00 ($96K) on 2020-10-06, disclosed to the SEC on 2020-10-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 237,149 | $0 | 0.0% |
| 2 | $19.00 | 5,030 | $96K | 100.0% |
| Total | $0.39 avg | 242,179 | $96K | 100% |
| Filing → |
| OPNT | SELL | 2010-07-29 | $4K | — | Filing → |
| OPNT | SELL | 2010-06-16 | $85K | — | Filing → |
| OPNT | SELL | 2010-06-15 | $314K | — | Filing → |